C

Captor Therapeutics SA
WSE:CTX

Watchlist Manager
Captor Therapeutics SA
WSE:CTX
Watchlist
Price: 78.4 PLN -3.21% Market Closed
Market Cap: zł433.6m

Net Margin

-353.5%
Current
Improving
by 23.1%
vs 3-y average of -376.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-353.5%
=
Net Income
zł-39.2m
/
Revenue
zł11.1m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-353.5%
=
Net Income
zł-39.2m
/
Revenue
zł11.1m

Peer Comparison

Country Company Market Cap Net
Margin
PL
Captor Therapeutics SA
WSE:CTX
433.6m PLN
Loading...
IN
Aaswa Trading and Exports Ltd
BSE:512038
23.9T INR
Loading...
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR
Loading...
US
GE Vernova LLC
NYSE:GEV
190.6B USD
Loading...
US
China Industrial Group Inc
OTC:CIND
121B USD
Loading...
US
Schlumberger NV
NYSE:SLB
73.4B USD
Loading...
US
Baker Hughes Co
NASDAQ:BKR
56.2B USD
Loading...
IN
GTV Engineering Ltd
BSE:539479
4.8T INR
Loading...
US
CoreWeave Inc
NASDAQ:CRWV
51.3B USD
Loading...
CH
Galderma Group AG
SIX:GALD
34.6B CHF
Loading...
US
Reddit Inc
NYSE:RDDT
36.6B USD
Loading...

Market Distribution

Lower than 93% of companies in Poland
Percentile
7th
Based on 886 companies
7th percentile
-353.5%
Low
-9 940 700% — -3.7%
Typical Range
-3.7% — 9.1%
High
9.1% — 196 605.3%
Distribution Statistics
Poland
Min -9 940 700%
30th Percentile -3.7%
Median 2.9%
70th Percentile 9.1%
Max 196 605.3%

Captor Therapeutics SA
Glance View

Market Cap
433.6m PLN
Industry
N/A

Captor Therapeutics SA engages in the development of protein degradation drugs for cancer and autoimmune diseases. The company is headquartered in Wroclaw, Woj. Dolnoslaskie and currently employs 98 full-time employees. The company went IPO on 2021-04-19. The firm works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The firm covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.

CTX Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-353.5%
=
Net Income
zł-39.2m
/
Revenue
zł11.1m
What is Captor Therapeutics SA's current Net Margin?

The current Net Margin for Captor Therapeutics SA is -353.5%, which is above its 3-year median of -376.6%.

How has Net Margin changed over time?

Over the last 3 years, Captor Therapeutics SA’s Net Margin has increased from -853.4% to -353.5%. During this period, it reached a low of -872.6% on Sep 30, 2022 and a high of -211.3% on Sep 30, 2024.

Back to Top